357436-36-3

Upstream product

• 209968-86-5 4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-1,2-diacetate 5-(4-methylbenzenesulfonate)-L-lyxofuranose 
• 357436-34-1 1-[2-O-acetyl-3,5-di-O-benzyl-4-(p-toluenesulfonyloxymethyl)-β-D-ribofuranosyl]-2-pyridone 
• 357436-35-2 1-(3,5-di-O-benzyl-2-O,4-C-methylene-β-D-ribofuranosyl)-2-pyridone 
• 142-08-5 2-Pyridone 
• 40615-36-9 4,4'-dimethoxytrityl chloride 
• 357436-33-0 1-(2-O,4-C-methylene-β-D-ribofuranosyl)-2-pyridone 

Relevant academic research and scientific papers

NOVEL NUCLEOSIDE ANALOGS AND OLIGONUCLEOTIDE DERIVATIVES CONTAINING THESE ANALOGS

Nucleoside analogues expressed by the following general formula ???where B represents an aromatic base having carbonyl oxygen at the 2-position, or a 2-hydroxyphenyl group, or oligonucleotide derivatives containing one or more of the nucleoside analogues

Stable oligonucleotide-directed triplex formation at target sites with CG interruptions: Strong sequence-specific recognition by 2′,4′-bridged nucleic-acid-containing 2-pyridones under physiological conditions

A sequence of double-stranded DNA (dsDNA) which can be recognized by a triplex-forming oligonucleotide (TFO) is limited to a homopurine-homopyrimidine sequence. To develop novel nucleoside analogues which recognize CG interruption in homopurine-homopyrimi